Brief: Alzinova: Delay In The Supply Of Material For The Clinical Trial Due To Additional Analytical Work

Alzinova AB

21/08/2020 07:11

Aug 21 (Reuters) - Alzinova AB  ALZ.ST :
    * ALZINOVA ANNOUNCES A DELAY IN THE SUPPLY OF MATERIAL FOR
THE
CLINICAL TRIAL DUE TO ADDITIONAL ANALYTICAL WORK
    * ADDITIONAL ANALYTICAL WORK MUST BE PERFORMED.
    * ONGOING ANALYSIS OF TECHNICAL BATCH HAS NOT BEEN COMPLETED
IN
TIME,
    * SUPPLY OF MATERIAL FOR CLINICAL PHASE 1B STUDY IS DELAYED.
    * DELIVERY OF DRUG FOR STUDY IS NOW ESTIMATED TO Q1 OF 2021
    * STUDY IS EXPECTED TO COMMENCE WITH FIRST PATIENT'S FIRST
DOSE
DURING Q2 OF 2021.
    * WE WILL NOT BE ABLE TO INITIATE CLINICAL STUDY DURING Q4
THIS
YEAR AS PREVIOUSLY COMMUNICATED

Source text for Eikon:  ID:nWkr16vyds 
Further company coverage:  ALZ.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))